NCT02884622View on ClinicalTrials.gov

DNA Methylation and Lung Disease in Cystic Fibrosis

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

August 31, 2016

Conditions
Cystic Fibrosis
Interventions
OTHER

nasal epithelial

CF patients with the same procedures as in the usual management of routine care, only the sampling nasal epithelial cells will be added

OTHER

Blood sampling

CF patients with the same procedures as in the usual management of routine care, only the sampling 5ml additional blood will be taken

Trial Locations (1)

34295

UHMontpellier, Montpellier

All Listed Sponsors
collaborator

Vaincre la Mucoviscidose

OTHER

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

University Hospital, Montpellier

OTHER

NCT02884622 - DNA Methylation and Lung Disease in Cystic Fibrosis | Biotech Hunter | Biotech Hunter